Search
-
News
MSK experts discuss risk factors, symptoms, and treatment for male breast cancer.
… Monday, September 26, 2022 Breast cancer in men accounts for less than 1% of all cases of breast cancer . But because breast cancer is so common, that still amounts to about 2,700 cases in the United States every year. The current treatments for men with breast cancer are largely based on what doctors
-
DermatologistI am a dermatologist who focuses on caring for people with basal cell carcinoma, squamous cell carcinoma, and early-stage melanoma. I have special training in Mohs surgery, laser surgery, and other dermatologic procedures.
… Dermatologist & Mohs Surgeon Job Title Associate Director, Mohs Micrographic and Dermatologic Surgery I am a dermatologist who focuses on caring for people with basal cell carcinoma , squamous cell carcinoma , early-stage melanoma , and rare types of skin cancers. I have special training in Mohs surgery
-
Dermatologist
Soy una dermatóloga que se enfoca en el cuidado de personas con carcinoma de células basales, carcinoma de células escamosas y melanoma en etapa temprana. Tengo capacitación especial en cirugía de Mohs, cirugía láser y otros procedimientos dermatológicos.
… Dermatologist & Mohs Surgeon Job Title Directora asociada, Cirugía Micrográfica y Dermatológica Mohs Soy una dermatóloga que se enfoca en el cuidado de personas con carcinoma de células basales , carcinoma de células escamosas , melanoma en etapa temprana y tipos raros de cánceres de piel. Tengo capacitación
-
News
Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes
… Thursday, December 13, 2018 Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes, which are collectively present in 16 percent of patients, as well as potentially actionable
-
The Prasad Adusumilli Lab
… Job Title Senior Research Scientist Current Position Principal Scientist, Johnson & Johnson, Belgium Education Biotechnology and Biotherapy, Paris Diderot University, Paris, France; MS, Cardiovascular Physiology, Paris Descartes University, Paris, France; MS, Biology Engineering, The University of Science
-
MSK’s Parker Institute members will focus on three areas: Improving Adoptive Cell Therapy, Checkpoint Blockade Nonresponders, and Tumor Antigen Discovery. Learn about the research.
… The research of Memorial Sloan Kettering’s Parker Institute members focuses on four main areas: Improving Adoptive Cell Therapy Engineering T cells with chimeric antigen receptors (CARs) directed to CD19 on cancer cells has proven to be a powerful way to treat some forms of leukemia. The challenge now
-
Computational Oncology
Dr. Soldatov’s research seeks to characterize the mechanisms of cell fate decisions that coordinate tissue function and quantify how distortions of these mechanisms shape the course of cancer evolution.
… Job Title Assistant Attending, Computational Oncologist Dr. Soldatov joined the Computational Oncology Service in 2022 as an Assistant Attending. Dr. Soldatov’s research aims to characterize mechanisms of cell fate decisions that coordinate tissue function and quantify how distortions of these mechanisms
-
Thoracic Medical OncologistI am a medical oncologist specializing in the care of patients with lung cancer. My research interest lies in developing new therapies for patients with squamous cell carcinomas of the lung. Treatment options for patients with this type of lung cancer havelagged behind those for patients with lung adenocarcinomas. We are, however, beginning to unravel the molecular complexity of this disease, which we hope will herald in a new era of personalized medicine for our patients.
… Thoracic Medical Oncologist Job Title Clinical Director, Thoracic Oncology Service I am a medical oncologist specializing in the care of patients with lung cancer. My research interest lies in developing new therapies for patients with squamous cell carcinomas of the lung. Treatment options for patients
-
Thoracic Medical Oncologist
Soy oncólogo médico especializado en el cuidado de pacientes con cáncer pulmonar. Mi interés de investigación radica en el desarrollo de nuevas terapias para pacientes con carcinomas de células escamosas de pulmón. Las opciones de tratamiento para pacientes con este tipo de cáncer pulmonar se han quedado atrás respecto de las de pacientes con adenocarcinomas de pulmón. Sin embargo, estamos comenzando a desentrañar la complejidad molecular de esta enfermedad, que esperamos anuncie una nueva era de medicina personalizada para nuestros pacientes.
… Thoracic Medical Oncologist Job Title Director clínico, Servicio de Oncología Torácica Soy oncólogo médico especializado en el cuidado de pacientes con cáncer pulmonar. Mi interés de investigación radica en el desarrollo de nuevas terapias para pacientes con carcinomas de células escamosas de pulmón.
-